Registration Options

Webinar Date: Every other month: March 14, May 16, and July 18 (See "Add to Calendar" section for a listing of all dates)
Activity Dates: 03/14/2024 - 06/30/2027

Session Summary

Join your colleagues to dialogue about challenging substance use disorder (SUD) cases where evidence can’t be uniformly applied and doesn’t always exist. Through 30 minutes of facilitated case discussion and debate, participants will problem solve solutions offering all the opportunity to learn. Though answers aren’t always available, together we chase down the possibilities and improve patient care!

Once registered, you will be able to review the posted case presentation for each session, which will be made available 2 weeks prior to each webinar.

*Note: Case presentation sessions will not be recorded, so don’t miss out on these live webinars and an opportunity for valuable discussion and learning with colleagues.

 


March 14, 2024, 11:00-11:30 AM Central: Buprenorphine Treatment for Opioid Use Disorder in Pregnancy

Case Overview: This session will discuss the use of buprenorphine for opioid use disorder in pregnancy and the post-partum period. It will briefly summarize pharmacokinetic changes relevant to buprenorphine metabolism that occur during pregnancy as well as review literature that discusses variability of buprenorphine doses during these periods. Discussion will summarize key considerations to factor in when approaching buprenorphine dosing in the post-partum period. 

Moderator: Aaron Salwan, PharmD, MPH, BCPP

Case Presenters:

Jacky Parizher, PharmD

Dr. Parizher is a PGY2 Psychiatric Pharmacy resident at the San Francisco Department of Public Health (SFDPH) and am originally from Los Angeles, CA. She completed her pharmacy school education at UCSF and my PGY-1 Pharmacy Practice residency at San Francisco General Hospital/SFDPH. Throughout her residency training, she has had the opportunity to work with a diverse patient population who often have a co-occurring psychiatric and substance use disorder diagnoses. During her time as a PGY-2 resident, she had a Substance Use Disorder rotation where she initiated and managed buprenorphine for patients while visiting them in their supportive housing units. Dr. Parizher hopes to continue managing substance use disorders in her future career. 

Hannah Van Ochten, PharmD, MPH, BCPP, APh

​​Dr. Van Ochten is a psychiatric clinical pharmacist at the San Francisco Department of Public Health. She completed a PGY2 in psychiatric pharmacy at the San Francisco Department of Public Health/SF General Hospital, a PGY1 at Denver Health and a PharmD/MPH at the University of Minnesota. Currently, she operates under collaborative practice agreements at two clinics to manage a caseload of patients with mental health diagnoses and substance use disorders. At these two clinics, Dr. Van Ochten also work with providers, nurses and other health care professionals to provide group education and individual consultation. Additionally, she staffs at CBHS Pharmacy, a low-barrier specialty pharmacy that provides intensive counseling on starting/continuing buprenorphine. Her education and training allows her to care for many patients with OUD, and to provide presentations and education to a wide variety of audiences. 

 

 


May 16, 2024, 11:00-11:30 AM Central: “BenzNO?” Benzo-sparing Regimens for the Management of Alcohol Withdrawal

Case Overview: In the context of polysubstance withdrawal, symptom-triggered treatment using CIWA scoring may lead to over or under-treatment of alcohol withdrawal as many withdrawal syndromes share similar symptoms, making differentiation a challenge. This session will focus on the controversy behind symptom-based treatment of alcohol withdrawal and discuss the implementation of a benzodiazepine-sparing approach.

 

Moderator: Troy Moore, PharmD, MS, BCPP

Case Presenters:

 

    

Miranda Hetrick, PharmD

Dr. Hetrick is second-year pharmacy resident specializing in pain management and palliative care at the Hospital of the University of Pennsylvania. Her experience includes treating patients with complex polysubstance use and withdrawal, encompassing alcohol, benzodiazepine, and opioid use disorder within the acute care setting. 

 

Tanya Uritsky, PharmD, BCPP

Dr. Uritsky is the Opioid Stewardship Coordinator at the Hospital of the University of Pennsylvania (HUP). She completed post-graduate training in pain management and palliative care and was a founding member of the HUP Palliative Care Service. She is Co-Chair of Penn Medicine’s Opioid Task Force and Past-President of the Society of Pain and Palliative Care Pharmacists. Dr. Uritsky also consults with care teams on patients with complex pain and speaks nationally and internationally. She was awarded 2015 PAINWeek Palliative Care Practitioner of the Year, the 2020 PSHP Joe E. Smith Award and the 2023 PSHP Innovative and Collaborative Practice Award.

 

 


July 18,2024, 11:00-11:30 AM Central: Never Say Never: Exploring the Prescribing of Controlled Substances in Patients with a History of Substance Use Disorder

Case Overview: Individuals with a history of substance use disorder often have ongoing medical issues that necessitate treatment with a controlled substance. Stigma regarding use of controlled substances in this population may hinder utilization of evidence-based treatment. This session will discuss the nuances of prescribing controlled substances in patients with a history of substance use disorder.

 

Moderator: Marnie Noel, PharmD, BCPP

Case Presenter:

Anne Ottney, PharmD, BCPS

Dr. Anne Ottney is currently a Professor at Ferris State University College of Pharmacy with a practice site at the Sparrow/Michigan State University Family Medicine Residency Clinics in Lansing. She is a board certified pharmacotherapy specialist. Her interest in this topic was sparked by her role on an interprofessional collaborative care team that specializes in managing patients with complex mental health needs, including substance use disorders.

 

Webinar Series Dates (Add to Calendar)

You must be signed in as a member to view the SUD Scoop dates.

Disclosure

The SUD Scoop Series is an unaccredited member-driven initiative to facilitate dialogue among psychiatric pharmacy professionals. While presenters are encouraged to disclose any conflicts and to use the best evidence available, the presentations are not peer reviewed and attendees should accordingly verify details prior to making significant practice changes.

Continuing Education Credit and Disclosures

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.